Recovered COVID-19 patients may need only a single vaccine dose, suggests study
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune […]
» Read morenohealthproblemsnews.com
Home »
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune […] The onset of the coronavirus disease 2019 (COVID-19) brought about intensive research on the biological characteristics of the pathogen responsible, […] The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use […] Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term. But the longer-term case burden and […] A recent theoretical paper, currently available on the medRxiv* preprint server, unveils a novel vaccination model that shows how a […] Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe respiratory syndrome coronavirus 2 (SARS-CoV-2), cases […] Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe respiratory syndrome coronavirus 2 (SARS-CoV-2), cases […] Stargardt disease is an inherited eye disease. Its onset is typically in adolescence and it is among the leading causes […] Taenia solium—also called pork tapeworm—is a parasite which causes disease around the world, particularly in very poor communities with deficient […] Patients with irregular heartbeats, or arrhythmia, have few effective treatment options—available drugs are not always effective, and an implanted defibrillator […]
Recovered COVID-19 patients may need only a single vaccine dose, suggests study
Neutralizing antibodies to SARS-CoV-2 in mice depend on Fc effector function
Janssen’s vaccine added to list of safe, effective tools against COVID-19
Delaying second doses of COVID-19 vaccines has benefits, but longer-term results rely on robust immunity
A model of vaccine-derived herd immunity against COVID-19 in heterogeneous populations
Ivermectin may not be the ‘silver bullet’ antiviral against COVID-19
Ivermectin may not be the ‘silver bullet’ antiviral against COVID-19
New ways to prove efficacy of emerging treatments for macular diseases
Study gauges efficacy of drugs against pork tapeworm
New model of irregular heartbeat could boost drug efficacy